glp-1 cardiovascular outcomes 2025 news Can one drug do it all? Reviewing the expanding clinical universe of agonists The cardiovascular effects of GLP-1

The research suggests these patients may particularly benefit from GLP-1 therapy, as it addresses multiple aspects of their complex symptom picture

So lets say you eat a big meal, lots of carbohydrates

Might they, then, have nutrient sensors of their own

Lisco and colleagues published a review of the risks of GLP-1s and thyroid cancer in the journal Endocrine Connections in 2023, and although they describe evidence for a risk of thyroid cancer, they conclude: It is reasonable to continue prescribing GLP-1RAs due to the evidence of more relevant and well-recognized antihyperglycemic, cardiovascular, and renal benefits, with the management staying within current recommendations. If you are considering taking a GLP-1 but are concerned about the risk of thyroid cancer, you should discuss it with your doctor

Discharging capacity can't exceed 80% of the max capacity of the pack after full charging to ensure a good cycle performance